Body Mass Index and Prognostic Nutritional Index in HNSCC Treatment Outcomes

Overview

This study evaluates the role of Body Mass Index (BMI) and Prognostic Nutritional Index (PNI) as predictors of treatment adherence and survival outcomes in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) undergoing sequential chemoradiotherapy. Findings suggest that both BMI and PNI may serve as significant indicators of treatment completion and overall survival.

Background

Head and neck cancers, particularly head and neck squamous cell carcinomas (HNSCC), are a significant cause of cancer-related morbidity and mortality. The integration of chemotherapy and radiotherapy in treatment regimens aims to improve patient outcomes, yet treatment-related toxicity can hinder effectiveness. Identifying reliable predictors of treatment adherence and survival is crucial for optimizing therapeutic strategies.

Data Highlights

No specific numerical data provided in the article.

Key Findings

• Approximately 47% of HNSCC cases are diagnosed at a loco-regional stage.
• Induction chemotherapy can enhance the efficacy of subsequent chemoradiotherapy.
• Patients with poor responses to induction chemotherapy may require alternative treatment strategies.
• Treatment toxicity significantly impacts quality of life and survival outcomes.
• BMI and PNI are potential predictors of treatment adherence and survival in HNSCC patients.

Clinical Implications

Healthcare professionals should consider BMI and PNI when assessing treatment plans for patients with locally advanced HNSCC. Monitoring these indices may help identify patients at risk for treatment non-adherence and poor survival outcomes, allowing for timely interventions.

Conclusion

BMI and PNI are valuable indicators that can guide treatment decisions and improve survival outcomes in patients with locally advanced HNSCC undergoing sequential chemoradiotherapy. Further research is warranted to validate these findings in larger cohorts.

References

1. Pignon et al., MACH-NC Group, 2021 -- Meta-analysis of chemotherapy in head and neck cancer
2. NCCN GUIDELINES® INSIGHTS, 2025 -- Head and Neck Cancers
3. ASCO Post, 2026 -- Nutrition, Muscle Loss Compromises Survival in Patients With Cervical Cancer
4. SpringerLink, 2019 -- The Role of Inflammatory and Nutritional Biomarkers in Gastric Cancer
5. European Radiology, 2023 -- Predictive Value of Imaging Changes During Radiation Therapy for HNSCC
6. Enhanced outpatient nutritional interventions lead to improved weight and muscle preservation following esophageal cancer surgery: a retrospective, single-center study.
7. NCCN GUIDELINES® INSIGHTS - Head and Neck Cancers
8. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC)
9. Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials - PubMed